NCT03776071 · Interventional trial
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Overall registry status Completed
Phase 3
Conditions Glioblastoma
Delaware Valley sites
- Penn Medicine - Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory